Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMZ001 in Knee Osteoarthritis
NCT03691844Phase 3Completed
- Sponsor
- Amzell B.V.
- Start
- Oct 2018
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of diclofenac (AMZ001 formulation) in osteoarthritis (OA), sponsored by Amzell B.V.. Started Oct 2018; status: completed.
02
Drugs
diclofenac (AMZ001 formulation)
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03691844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03691844.